Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Ngm Biopharmaceuticals Inc (NGM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2018	12-2017	12-2006	12-2005
Cash Flows From Operating Activities
Net Income	-493	-14,159	N/A	N/A
Depreciation Amortization	6,347	6,682	N/A	N/A
Accounts receivable	-3,669	2,769	N/A	N/A
Accounts payable and accrued liabilities	3,484	-4,230	N/A	N/A
Other Working Capital	-23,581	-17,738	N/A	N/A
Other Operating Activity	10,315	9,263	0	0
Operating Cash Flow	$-7,597	$-17,413	$N/A	$N/A

Cash Flows From Investing Activities
Change In Deposits	44,573	3,626	N/A	N/A
PPE Investments	-5,844	-6,422	N/A	N/A
Investing Cash Flow	$38,729	$-2,796	$N/A	$N/A

Cash Flows From Financing Activities
Common Stock Issued	2,583	339	N/A	N/A
Common Stock Repurchased	-185	0	N/A	N/A
Other Financing Activity	-2,200	0	0	0
Financing Cash Flow	$198	$339	$N/A	$N/A

Beginning Cash Position	27,842	47,712	N/A	N/A
End Cash Position	59,172	27,842	N/A	N/A
Net Cash Flow	$31,330	$-19,870	$N/A	$N/A

Free Cash Flow
Operating Cash Flow	-7,597	-17,413	N/A	N/A
Capital Expenditure	-5,844	-6,422	N/A	N/A
Free Cash Flow	-13,441	-23,835	0	0